Cargando…

Baseline Perfusion Alterations Due to Acute Application of Quetiapine and Pramipexole in Healthy Adults

BACKGROUND: The dopaminergic system is implicated in many mental processes and neuropsychiatric disorders. Pharmacologically, drugs with dopamine receptor antagonistic and agonistic effects are used, but their effects on functional brain metabolism are not well known. METHODS: In this randomized cro...

Descripción completa

Detalles Bibliográficos
Autores principales: Michels, Lars, Scherpiet, Sigrid, Stämpfli, Philipp, Herwig, Uwe, Brühl, Annette B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137281/
https://www.ncbi.nlm.nih.gov/pubmed/27466220
http://dx.doi.org/10.1093/ijnp/pyw067
_version_ 1782471885782515712
author Michels, Lars
Scherpiet, Sigrid
Stämpfli, Philipp
Herwig, Uwe
Brühl, Annette B.
author_facet Michels, Lars
Scherpiet, Sigrid
Stämpfli, Philipp
Herwig, Uwe
Brühl, Annette B.
author_sort Michels, Lars
collection PubMed
description BACKGROUND: The dopaminergic system is implicated in many mental processes and neuropsychiatric disorders. Pharmacologically, drugs with dopamine receptor antagonistic and agonistic effects are used, but their effects on functional brain metabolism are not well known. METHODS: In this randomized crossover, placebo-controlled, and rater-blinded study, 25 healthy adults received an acute dose placebo substance (starch), quetiapine (dopamine receptor antagonist), or pramipexole (dopamine agonist of the nonergoline class) 1 hour before the experiment. Background-suppressed 2D pseudo-continuous arterial spin labeling was used to examine whole-brain baseline cerebral blood flow differences induced by the 3 substances. RESULTS: We found that quetiapine reduced perfusion in the occipital (early visual areas) and bilateral cerebellar cortex relative to placebo. In contrast, quetiapine enhanced cerebral blood flow (relative to placebo) in the striatal system (putamen and caudate nucleus) but also in the supplementary motor area, insular-, prefrontal- as well as in the pre- and postcentral cortex. Pramipexole increased cerebral blood flow compared with placebo in the caudate nucleus, putamen, middle frontal, supplementary motor area, and brainstem (substantia nigra), but reduced cerebral blood flow in the posterior thalamus, cerebellum, and visual areas. Pramipexole administration resulted in stronger cerebral blood flow relative to quetiapine in the hypothalamus, cerebellum, and substantia nigra. CONCLUSIONS: Our results indicate that quetiapine and pramipexole differentially modulate regional baseline cerebral blood flow. Both substances act on the dopaminergic system, although they affect distinct regions. Quetiapine altered dopaminergic function in frontal, striatal, and motor regions. In contrast, pramipexole affected cerebral blood flow of the nigrostriatal (striatum and substantia nigra) dopaminergic, but less the fronto-insular system.
format Online
Article
Text
id pubmed-5137281
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-51372812016-12-06 Baseline Perfusion Alterations Due to Acute Application of Quetiapine and Pramipexole in Healthy Adults Michels, Lars Scherpiet, Sigrid Stämpfli, Philipp Herwig, Uwe Brühl, Annette B. Int J Neuropsychopharmacol Regular Research Article BACKGROUND: The dopaminergic system is implicated in many mental processes and neuropsychiatric disorders. Pharmacologically, drugs with dopamine receptor antagonistic and agonistic effects are used, but their effects on functional brain metabolism are not well known. METHODS: In this randomized crossover, placebo-controlled, and rater-blinded study, 25 healthy adults received an acute dose placebo substance (starch), quetiapine (dopamine receptor antagonist), or pramipexole (dopamine agonist of the nonergoline class) 1 hour before the experiment. Background-suppressed 2D pseudo-continuous arterial spin labeling was used to examine whole-brain baseline cerebral blood flow differences induced by the 3 substances. RESULTS: We found that quetiapine reduced perfusion in the occipital (early visual areas) and bilateral cerebellar cortex relative to placebo. In contrast, quetiapine enhanced cerebral blood flow (relative to placebo) in the striatal system (putamen and caudate nucleus) but also in the supplementary motor area, insular-, prefrontal- as well as in the pre- and postcentral cortex. Pramipexole increased cerebral blood flow compared with placebo in the caudate nucleus, putamen, middle frontal, supplementary motor area, and brainstem (substantia nigra), but reduced cerebral blood flow in the posterior thalamus, cerebellum, and visual areas. Pramipexole administration resulted in stronger cerebral blood flow relative to quetiapine in the hypothalamus, cerebellum, and substantia nigra. CONCLUSIONS: Our results indicate that quetiapine and pramipexole differentially modulate regional baseline cerebral blood flow. Both substances act on the dopaminergic system, although they affect distinct regions. Quetiapine altered dopaminergic function in frontal, striatal, and motor regions. In contrast, pramipexole affected cerebral blood flow of the nigrostriatal (striatum and substantia nigra) dopaminergic, but less the fronto-insular system. Oxford University Press 2016-07-27 /pmc/articles/PMC5137281/ /pubmed/27466220 http://dx.doi.org/10.1093/ijnp/pyw067 Text en © The Author 2016. Published by Oxford University Press on behalf of CINP. http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Regular Research Article
Michels, Lars
Scherpiet, Sigrid
Stämpfli, Philipp
Herwig, Uwe
Brühl, Annette B.
Baseline Perfusion Alterations Due to Acute Application of Quetiapine and Pramipexole in Healthy Adults
title Baseline Perfusion Alterations Due to Acute Application of Quetiapine and Pramipexole in Healthy Adults
title_full Baseline Perfusion Alterations Due to Acute Application of Quetiapine and Pramipexole in Healthy Adults
title_fullStr Baseline Perfusion Alterations Due to Acute Application of Quetiapine and Pramipexole in Healthy Adults
title_full_unstemmed Baseline Perfusion Alterations Due to Acute Application of Quetiapine and Pramipexole in Healthy Adults
title_short Baseline Perfusion Alterations Due to Acute Application of Quetiapine and Pramipexole in Healthy Adults
title_sort baseline perfusion alterations due to acute application of quetiapine and pramipexole in healthy adults
topic Regular Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137281/
https://www.ncbi.nlm.nih.gov/pubmed/27466220
http://dx.doi.org/10.1093/ijnp/pyw067
work_keys_str_mv AT michelslars baselineperfusionalterationsduetoacuteapplicationofquetiapineandpramipexoleinhealthyadults
AT scherpietsigrid baselineperfusionalterationsduetoacuteapplicationofquetiapineandpramipexoleinhealthyadults
AT stampfliphilipp baselineperfusionalterationsduetoacuteapplicationofquetiapineandpramipexoleinhealthyadults
AT herwiguwe baselineperfusionalterationsduetoacuteapplicationofquetiapineandpramipexoleinhealthyadults
AT bruhlannetteb baselineperfusionalterationsduetoacuteapplicationofquetiapineandpramipexoleinhealthyadults